Gordon, Kenneth, Kim Papp, Melinda Gooderham, Akimichi Morita, Peter Foley, Diamant Tha?i, Sundeep Kundu, Renata Kisa, Lan Wei, and Subhashis Banergee. 2020. “BMS-986165, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor: Evaluation of Changes in Laboratory Parameters in Response to Treatment in a Phase 2 Trial in Psoriasis Patients”. SKIN The Journal of Cutaneous Medicine 4 (5):s28. https://doi.org/10.25251/skin.4.supp.28.